Pfizer Wins against Novopharm on Celebrex Patent Decision in Canadian Court

sai's picture
Submitted by on Thu, 05/03/2007 - 17:06.
in
0

 The Federal Court of Appeal of Canada in Toronto has blocked Teva's Novopharm  to launch its form of Celebrex in Canada according to Pfizer statement on May 1st  .

This ruling will prevent Teva Pharmaceutical Industries Ltd. from launching a copycat form of its Celebrex arthritis drug in the country until 2014.

 The Federal Court of Appeal of Canada in Toronto has blocked Teva's Novopharm  to launch its form of Celebrex in Canada according to Pfizer statement on May 1st  .

This ruling will prevent Teva Pharmaceutical Industries Ltd. from launching a copycat form of its Celebrex arthritis drug in the country until 2014.

Pfizer in December won an important round in another patent battle with Teva, when a Canadian federal court prevented the Novopharm affiliate from launching a generic version of Pfizer's Lipitor cholesterol fighter until a patent expires in July 2010.